Endothelin-1 (1-31) (Human)

Documents

Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-Val-Asn-Thr-Pro-Glu-His-Val-Val-Pro-Tyr (Disulfide bonds between Cys¹-Cys¹⁵ and Cys³-Cys¹¹)
: (M.W. 3628.2) C₁₆₂H₂₃₆N₃₈O₄₇S₅

Package	Price(Yen)	Availability
Vial 0.1 mg	20,000	Ships within 1-3 business days
Bulk Request

Solubility: 0.1% AcOH (0.1 mM)

A. Nakano, F. Kishi, K. Minami, H. Wakabayashi, Y. Nakaya, and H. Kido, J. Immunol., 159, 1987 (1997). (Original; New Endogenous Form)
F. Kishi, K. Minami, N. Okishima, M. Murakami, S. Mori, M. Yano, Y. Niwa, Y. Nakaya, and H. Kido, Biochem. Biophys. Res. Commun., 248, 387 (1998). (Pharmacol.)
M. Yoshizumi, D. Inui, N. Okishima, H. Houchi, K. Tsuchiya, H. Wakabayashi, H. Kido, and T. Tamaki, Eur. J. Pharmacol., 348, 305 (1998). (Pharmacol.)
M. Yoshizumi, S. Kim, S. Kagami, A. Hamaguchi, K. Tsuchiya, H. Houchi, H. Iwao, H. Kido, and T. Tamaki, Br. J. Pharmacol., 125, 1019 (1998). (Pharmacol.)
M. Yanagisawa and T. Masaki, Trends Pharmacol. Sci., 10, 374 (1989). (Review)
T. Sakurai, M. Yanagisawa, and T. Masaki, Trends Pharmacol. Sci., 13, 103 (1992). (Review)
A.F. James, Y. Urade, R.L. Webb, H. Karaki, I. Umemura, Y. Fujitani, K. Oda, T. Okada, R.W. Lappe, and M. Takai, Cardiovasc. Drug Rev., 11, 253 (1993). (Review)

Data Sheet